Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial

INTRODUCTION: The purpose was to compare two flexible regimens of intravitreal aflibercept (IVT-AFL) with fixed dosing every 8 weeks, beyond the first year of treatment, in patients with diabetic macular edema (DME). VIOLET was a 100-week, randomized, Phase IIIb, non-inferiority study in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Garweg, Justus G., Štefanickova, Jana, Hoyng, Carel, Niesen, Tobias, Schmelter, Thomas, Leal, Sergio, Sivaprasad, Sobha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123040/
https://www.ncbi.nlm.nih.gov/pubmed/35412227
http://dx.doi.org/10.1007/s12325-022-02119-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123040/
https://www.ncbi.nlm.nih.gov/pubmed/35412227
http://dx.doi.org/10.1007/s12325-022-02119-z

Ejemplares similares